Last edition
News about
D3 Bio Secures FDA IND Clearance for Two Oncology Programmes
The US FDA has cleared two Investigational New Drug (IND) applications from D3 Bio, paving the way for a phase I clinical trial of D3S-003 and a phase II combination study evaluating elisrasib (D3S-001) with D3S-002, marking a key step forward in the company’s oncology development pipeline.
FAR Biotech Sets Up Operations in Wisconsin, Expands QuantumAI Programmes
Far Biotech, part of the Johnson & Johnson Innovation JLABS ecosystem, is advancing a quantum mechanics-based, AI-powered approach to drug discovery as it expands operations in Madison, Wisconsin.
AGC Biologics’ Milan Cell and Gene Centre of Excellence will support the commercial rollout of Waskyra following US FDA and EU approvals, strengthening treatment options for patients with Wiskott-Aldrich syndrome.
FIU Researchers Advance Functional Precision Medicine for Hard to Treat Cancers
FIU researchers are advancing functional precision medicine for hard-to-treat cancers, with new funding accelerating drug sensitivity testing to identify personalized, effective therapies beyond conventional genetic approaches.
CDSCO Flags 167 Drug Samples as Substandard, Seven Found Spurious
India’s drug regulator has identified 167 medicine samples that failed quality tests and classified seven additional samples as spurious during routine surveillance conducted in December. The findings were released as part of the Central Drugs Standard Control Organisation’s (CDSCO) monthly drug alert.
India Cuts Review Period for Clinical Trial Drug Manufacturing to 45 Days
The central government has reduced the approval timeline for applications to manufacture drugs meant for clinical trials, a move aimed at accelerating clinical research and drug development in India.
HistoIndex, Houston Research Institute Collaborate to Enhance MASH Diagnosis Using AI
HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has entered into a strategic partnership with Houston Research Institute (HRI), a leading clinical research organization specialising in hepatology and gastroenterology, with a strong focus on metabolic liver disease.
Telangana Unveils Life Sciences Policy 2026-30
Telangana has unveiled its Life Sciences Policy 2026–30 with an ambition to rank among the world’s top five life sciences clusters by 2030, targeting USD 25 billion in investments while shifting the sector’s focus toward innovation-led growth and higher value creation.
Graph Therapeutics Taps Parse GigaLab to Accelerate AI-First Immunology Drug Discovery
Parse Biosciences and Graph Therapeutics have entered into a strategic partnership to build one of the largest and most comprehensive immune cell perturbation atlases to date.
ACG Packaging Materials Launches SuperPod
ACG Packaging Materials has launched SuperPod, a next-generation blister solution designed for seamless compatibility with existing high-speed packaging lines, offering manufacturers a balance of reliable performance, operational efficiency and enhanced sustainability options.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy